SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
Clinical trial NCT06516445 · UNKNOWN
Trial details
- NCT number
- NCT06516445
- Sponsor
- Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2025-06-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.